Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16611810rdf:typepubmed:Citationlld:pubmed
pubmed-article:16611810lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:16611810lifeskim:mentionsumls-concept:C0012634lld:lifeskim
pubmed-article:16611810lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:16611810lifeskim:mentionsumls-concept:C0003069lld:lifeskim
pubmed-article:16611810lifeskim:mentionsumls-concept:C0027882lld:lifeskim
pubmed-article:16611810lifeskim:mentionsumls-concept:C0028936lld:lifeskim
pubmed-article:16611810lifeskim:mentionsumls-concept:C0038590lld:lifeskim
pubmed-article:16611810lifeskim:mentionsumls-concept:C0085200lld:lifeskim
pubmed-article:16611810lifeskim:mentionsumls-concept:C0285890lld:lifeskim
pubmed-article:16611810lifeskim:mentionsumls-concept:C0282151lld:lifeskim
pubmed-article:16611810lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:16611810lifeskim:mentionsumls-concept:C1521733lld:lifeskim
pubmed-article:16611810lifeskim:mentionsumls-concept:C0443172lld:lifeskim
pubmed-article:16611810pubmed:issue15lld:pubmed
pubmed-article:16611810pubmed:dateCreated2006-4-13lld:pubmed
pubmed-article:16611810pubmed:abstractTextDysfunction of the 140 aa protein alpha-synuclein plays a central role in Lewy body disorders, including Parkinson's disease, as well as in multiple system atrophy. Here, we show that the expression of truncated human alpha-synuclein(1-120), driven by the rat tyrosine hydroxylase promoter on a mouse alpha-synuclein null background, leads to the formation of pathological inclusions in the substantia nigra and olfactory bulb and to a reduction in striatal dopamine levels. At the behavioral level, the transgenic mice showed a progressive reduction in spontaneous locomotion and an increased response to amphetamine. These findings suggest that the C-terminal of alpha-synuclein is an important regulator of aggregation in vivo and will help to understand the mechanisms underlying the pathogenesis of Lewy body disorders and multiple system atrophy.lld:pubmed
pubmed-article:16611810pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16611810pubmed:languageenglld:pubmed
pubmed-article:16611810pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16611810pubmed:citationSubsetIMlld:pubmed
pubmed-article:16611810pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16611810pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16611810pubmed:statusMEDLINElld:pubmed
pubmed-article:16611810pubmed:monthAprlld:pubmed
pubmed-article:16611810pubmed:issn1529-2401lld:pubmed
pubmed-article:16611810pubmed:authorpubmed-author:GoedertMichel...lld:pubmed
pubmed-article:16611810pubmed:authorpubmed-author:EmsonPiers...lld:pubmed
pubmed-article:16611810pubmed:authorpubmed-author:WilkinsonLawr...lld:pubmed
pubmed-article:16611810pubmed:authorpubmed-author:GhettiBernard...lld:pubmed
pubmed-article:16611810pubmed:authorpubmed-author:TofarisGeorge...lld:pubmed
pubmed-article:16611810pubmed:authorpubmed-author:SpillantiniMa...lld:pubmed
pubmed-article:16611810pubmed:authorpubmed-author:HumbyTrevorTlld:pubmed
pubmed-article:16611810pubmed:authorpubmed-author:O'ConnellMark...lld:pubmed
pubmed-article:16611810pubmed:authorpubmed-author:LambourneSara...lld:pubmed
pubmed-article:16611810pubmed:authorpubmed-author:Garcia...lld:pubmed
pubmed-article:16611810pubmed:authorpubmed-author:GossageHelenHlld:pubmed
pubmed-article:16611810pubmed:issnTypeElectroniclld:pubmed
pubmed-article:16611810pubmed:day12lld:pubmed
pubmed-article:16611810pubmed:volume26lld:pubmed
pubmed-article:16611810pubmed:ownerNLMlld:pubmed
pubmed-article:16611810pubmed:authorsCompleteYlld:pubmed
pubmed-article:16611810pubmed:pagination3942-50lld:pubmed
pubmed-article:16611810pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:16611810pubmed:meshHeadingpubmed-meshheading:16611810...lld:pubmed
pubmed-article:16611810pubmed:meshHeadingpubmed-meshheading:16611810...lld:pubmed
pubmed-article:16611810pubmed:meshHeadingpubmed-meshheading:16611810...lld:pubmed
pubmed-article:16611810pubmed:meshHeadingpubmed-meshheading:16611810...lld:pubmed
pubmed-article:16611810pubmed:meshHeadingpubmed-meshheading:16611810...lld:pubmed
pubmed-article:16611810pubmed:meshHeadingpubmed-meshheading:16611810...lld:pubmed
pubmed-article:16611810pubmed:meshHeadingpubmed-meshheading:16611810...lld:pubmed
pubmed-article:16611810pubmed:meshHeadingpubmed-meshheading:16611810...lld:pubmed
pubmed-article:16611810pubmed:meshHeadingpubmed-meshheading:16611810...lld:pubmed
pubmed-article:16611810pubmed:meshHeadingpubmed-meshheading:16611810...lld:pubmed
pubmed-article:16611810pubmed:meshHeadingpubmed-meshheading:16611810...lld:pubmed
pubmed-article:16611810pubmed:meshHeadingpubmed-meshheading:16611810...lld:pubmed
pubmed-article:16611810pubmed:meshHeadingpubmed-meshheading:16611810...lld:pubmed
pubmed-article:16611810pubmed:meshHeadingpubmed-meshheading:16611810...lld:pubmed
pubmed-article:16611810pubmed:meshHeadingpubmed-meshheading:16611810...lld:pubmed
pubmed-article:16611810pubmed:meshHeadingpubmed-meshheading:16611810...lld:pubmed
pubmed-article:16611810pubmed:meshHeadingpubmed-meshheading:16611810...lld:pubmed
pubmed-article:16611810pubmed:year2006lld:pubmed
pubmed-article:16611810pubmed:articleTitlePathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders.lld:pubmed
pubmed-article:16611810pubmed:affiliationCentre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 2PY, United Kingdom.lld:pubmed
pubmed-article:16611810pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16611810pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:16611810pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:6622entrezgene:pubmedpubmed-article:16611810lld:entrezgene
entrez-gene:20617entrezgene:pubmedpubmed-article:16611810lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16611810lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16611810lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16611810lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16611810lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16611810lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16611810lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16611810lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16611810lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16611810lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16611810lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16611810lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16611810lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16611810lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16611810lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16611810lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16611810lld:pubmed